A data-driven approach for the discovery of biomarkers associated with thyroid eye disease

被引:3
作者
Zou, Huihui [1 ]
Xu, Weiwei [1 ]
Wang, Ying [2 ]
Wang, Zhihong [1 ]
机构
[1] Dezhou Peoples Hosp, Dept Ophthalmol, Dezhou 253000, Peoples R China
[2] Dezhou Womens & Childrens Hosp, Dept Ophthalmol, Dezhou, Shandong, Peoples R China
关键词
Thyroid eye disease; Autoimmune disease; Biomarker; Graves’ disease; INTERLEUKIN-RELATED GENES; GRAVES OPHTHALMOPATHY; ORBITAL DECOMPRESSION; PATHOGENESIS; RECEPTOR; SMOKING; PATHWAY; UPDATE; TSH;
D O I
10.1186/s12886-021-01903-9
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Thyroid eye disease (TED) is the most common autoimmune disease and usually occurs in patients with hyperthyroidism. In this disease, eye-related tissue, such as eye muscles, eyelids, tear glands, etc., become inflated, which causes the eyes and eyelids to become red, swollen, and uncomfortable. The pathophysiology of this disease is still poorly known. Aim This study aims to discover potential biomarkers and regulatory pathways of TED which will not only help to diagnose the disease and understand orbital involvement in thyroid dysfunction but also provide an insight for better therapeutics. Methods We applied a data-driven approach by combining gene biomarkers both from published literature and computationally predicted from microarray gene expression data. Further, the DAVID tool is used for Gene Ontology-based enrichment analysis. Results We obtained a total of 22 gene biomarkers, including 18 semi-automatically curated from the literature and 4 predicted using data-driven approaches, involved in the pathogenesis of TED that can be used as potential information for therapeutic targets. Further, we constructed a regulatory pathway of TED biomarkers comprises of 310 connected components, and 1134 interactions using four prominent interaction databases. Conclusion This constructed pathway can be further utilized for disease dynamics and simulation studies.
引用
收藏
页数:10
相关论文
共 59 条
[41]   CONCOMITANT EUTHYROID GRAVES OPHTHALMOPATHY AND ISOLATED OCULAR MYASTHENIA-GRAVIS [J].
RAEF, H ;
LADINSKY, M ;
AREM, R .
POSTGRADUATE MEDICAL JOURNAL, 1990, 66 (780) :849-852
[42]  
Raza K., 2019, DIFFERENTIAL EXPRESS, P1, DOI [10.1007/978-3-030-17938-0_26, DOI 10.1007/978-3-030-17938-0_26]
[43]  
Raza K., 2013, CONFLUENCE 2013, V2013, P461, DOI DOI 10.1049/CP.2013.2357
[44]  
Raza K, 2016, ADV BIOINFORM BIOMED, P216, DOI 10.4018/978-1-5225-0427-6.ch011
[45]   Reconstruction, Topological and Gene Ontology Enrichment Analysis of Cancerous Gene Regulatory Network Modules [J].
Raza, Khalid .
CURRENT BIOINFORMATICS, 2016, 11 (02) :243-258
[46]   Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy [J].
Smith, Terry J. ;
Hegedus, Laszlo ;
Douglas, Raymond S. .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 26 (03) :291-302
[47]   The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible [J].
Szklarczyk, Damian ;
Morris, John H. ;
Cook, Helen ;
Kuhn, Michael ;
Wyder, Stefan ;
Simonovic, Milan ;
Santos, Alberto ;
Doncheva, Nadezhda T. ;
Roth, Alexander ;
Bork, Peer ;
Jensen, Lars J. ;
von Mering, Christian .
NUCLEIC ACIDS RESEARCH, 2017, 45 (D1) :D362-D368
[48]  
Thompson EH, 2019, ENDOCR PRACT, V25
[49]   Cigarette smoking and thyroid eye disease: a systematic review [J].
Thornton, J. ;
Kelly, S. P. ;
Harrison, R. A. ;
Edwards, R. .
EYE, 2007, 21 (09) :1135-1145
[50]   Association between polymorphism within interleukin related genes and Graves' disease: a meta-analysis of 22 case-control studies [J].
Tu, Yaqin ;
Fan, Guorun ;
Zeng, Tianshu ;
Cai, Xiong ;
Kong, Wen .
ONCOTARGET, 2017, 8 (58) :98993-99002